Point State Capital LP Qiagen N.V. Transaction History

Point State Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$42.23 - $54.3 $7.6 Million - $9.77 Million	-180,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$50.62 - $56.47 $1.85 Million - $2.06 Million	36,480 Added 25.42%	180,000 $10 Million
Q3 2021 Nov 15, 2021	SELL	$46.55 - $56.83 $8.54 Million - $10.4 Million	-183,480 Reduced 56.11%	143,520 $7.42 Million
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $7.27 Million - $8.28 Million	157,000 Added 92.35%	327,000 $15.8 Million
Q1 2021 May 14, 2021	BUY	$46.25 - $56.02 $7.86 Million - $9.52 Million	170,000 New	170,000 $8.28 Million

Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $9.42 Million - $11.2 Million	-204,317 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $8.69 Million - $10.7 Million	204,317 New	204,317 $10.7 Million
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $1.97 Million - $2.22 Million	-50,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $23.8 Million - $29.8 Million	-716,039 Reduced 93.47%	50,000 $2.08 Million
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $19.5 Million - $33 Million	766,039 New	766,039 $25.9 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.36B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.